Bluejay Diagnostics Announces SYMON-I Study Results; IL-6 Levels Within 24 Hours of ICU Admission Predict 28-Day Mortality in Sepsis and Septic Shock Patients; Findings to Be Validated in SYMON-II Study
Bluejay Diagnostics Announces SYMON-I Study Results; IL-6 Levels Within 24 Hours of ICU Admission Predict 28-Day Mortality in Sepsis and Septic Shock Patients; Findings to Be Validated in SYMON-II Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.